Aspen Healthcare, a division of Aspen Pharmacare Holdings Limited, a JSE-listed global multinational specialty pharmaceutical company, was founded in 2009 to bring the Aspen Group’s expanding portfolio of pharmaceutical and consumer healthcare products to the Middle East, North Africa and Turkey (MENAT).
Headquartered in Dubai, the commercial operation was established in 2010 when the first partnerships were sealed to leverage the global acquisitions in the region. From 3 employees in 2009 to more than 200 today, Aspen Healthcare rapidly grew, establishing itself as a key healthcare player in the MENAT region.
Aspen Europe was founded in 2014 to bring the Aspen Group’s expanding portfolio of pharmaceutical and consumer healthcare products to Europe. In March 2023, the Europe and MENAT regions merged into one growth region to achieve the objectives with a specific focus on synergies, commercial excellence, and portfolio development. This strategic decision was made following an in-depth review of the international commercial portfolio completed by the Aspen Group Executives to ensure focus and alignment with Aspen’s business strategy geared towards delivering its stated objectives.
Aspen Healthcare strives to offer patients and stakeholders the best possible experience throughout the region and beyond.
Regional CEO
Europe & Middle East
Head of Supply Chain & Projects
Europe & Middle East
Head of Human Capital
Europe & Middle East
Head of Business Development & Marketing
Europe & Middle East
General ManagerFrance & Head of Commercial
Southern Europe
Head of Pharma Affairs EU QPPV
Europe & Middle East
Head of CommercialDACH
Head of Commercial Finance & Operations
Europe & Middle East
Head of Commercial
Middle East
Head of Commercial
Northern Europe
Head of Commercial
GCC
Regional CEO
Europe & Middle East
Head of Supply Chain & Projects
Europe & Middle East
Head of Human Capital
Europe & Middle East
Head of Business Development & Marketing
Europe & Middle East
General ManagerFrance & Head of Commercial
Southern Europe
Head of Pharma Affairs EU QPPV
Europe & Middle East
Head of CommercialDACH
Head of Commercial Finance & Operations
Europe & Middle East
Head of Commercial
Middle East
Head of Commercial
Northern Europe
Head of Commercial
GCC
“To deliver value to all our stakeholders as a responsible corporate citizen that provides high quality, affordable medicines and products globally” encapsulates Aspen’s inherent approach of conducting business ethically, with integrity and with a commercial wisdom which strives to enhance the economic and social well-being of our patients, consumers, investors, employees, customers and business partners.
LIVE THE VALUES AND YOU WON’T NEED TO TALK ABOUT THEM
Our integrity is not negotiable
We constantly search for better ways of doing things
We strive to be the best we can be to deliver the highest standards
We go the extra mile, seeking to exceed expectations
We optimise our performance by pulling together
Aspen Pharmacare has a zero tolerance for unethical behavior and is committed to ensuring that all of its employees and business partners adhere to established policies and guidelines. Please click below to learn more about Aspen Pharmacare’s Codes of Conduct, Tip-Off Anonymous Hotline and Conflicts of Interest.
With a 170-year heritage, Aspen is a global specialty and branded multinational pharmaceutical company with a presence in both emerging and developed markets. We have more than 9 300 employees at 63 established offices in over some 46 countries and territories and we improve the health of patients in more than 115 countries through our high quality, affordable medicines.
Aspen focuses on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets through our key business segments. Our key business segments are Manufacturing and Commercial Pharmaceuticals comprising Injectable products, Prescription and OTC medicines. Our manufacturing capabilities cover a wide variety of product types including steriles, oral solid dose, liquids, semi-solids, biologicals and active pharmaceutical ingredients.
We operate 24 manufacturing facilities across 15 sites and we hold international manufacturing approvals from some of the most stringent global regulatory agencies including, among others, the United States Food and Drug Administration, the Australian Therapeutic Goods Administration and the European Directorate for the Quality of Medicines.
